01-12 UBS Rejects Proposed Swiss Banking Rules MT
01-12 Novartis eyes more bolt-on acquisitions, CEO says RE
01-12 Swiss Life Places CHF225 Million Hybrid Bond Due 2042 MT
01-12 Swiss Market Index Begins Week Flat; UBS, Novartis Edge Lower MT
01-12 Swiss Life successfully places a hybrid bond totalling CHF 225 mln RE
01-12 SciNeuro, Novartis sign $1.7 billion licensing deal to develop Alzheimer's drugs RE
01-12 BC Ferries Taps ABB to Equip Four New Passenger, Car Ferries MT
01-12 BNP Paribas Downgrades Swiss Life to Underperform, Lifts PT MT
01-12 UBS Group Rejects Switzerland's Proposed Disproportionate' Changes to Capital Rules MT
01-12 UBS Group Urges Switzerland to Reassess Alternatives to Capital Plan DJ
01-12 UBS Group AG rejects proposed full deduction of foreign subsidiaries from common equity tier 1 (CET1) RE
01-12 UBS rejects proposed Swiss rules, calls for less costly alternatives RE
01-12 RBC Cuts Holcim Financial Projections on Currency Exchange, Weather Trends; Price Target Down MT
01-12 Swiss stocks - Factors to watch on January 12 RE
01-12 Berenberg Expects 'Solid Trading Outlook' for Holcim in FY26; Price Target Up MT
01-09 Novartis to Develop New US Radioligand Therapy Manufacturing Site in Florida MT
01-09 Novartis to Build RLT Manufacturing Facility in Florida MT
01-09 Novartis to Build Radioligand Therapy Facility in Florida DJ
01-09 Aritzia Offering Compelling Growth Story, UBS Says MT
01-09 Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida RE
01-09 Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment DJ
01-09 Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment DJ
01-09 Medilink says it has signed an additional exclusive licensing agreement with Roche RE
01-08 Nestlé recalls some baby formula in Ethiopia, regulatory body warns consumers RE
01-08 American Homes 4 Rent shares slip 1.5% after Mizuho downgrade, UBS PT cut RE
01-08 UBS Adjusts Price Target on Amrize to $57 From $53, Maintains Neutral Rating MT
01-08 Grupo Santander Kicks Off Nestlé Coverage with Outperform Rating MT
01-08 BNP Paribas Downgrades Logitech to Neutral Rating, Cuts PT MT
01-08 Shell flags chemicals and products unit loss, raising doubts over $3.5 billion buyback RE
01-08 UAE Regulator Issues Nestlé Infant Formula Products Recall Over Raw Material Issue MT
01-08 Berenberg Expects Zurich Insurance's FY26 Outlook to Outpace Market Expectations; Buy Rating Maintained MT
01-08 UBS Group to Redeem $1.3 Billion of Senior Notes MT
01-07 Sector Update: Financial Stocks Decline Late Afternoon MT
01-07 UAE recalls some Nestle infant formula products, state news agency says RE
01-07 Sector Update: Financial Stocks Decline Wednesday Afternoon MT
01-07 UBS Wins Key Political Support for Capital Compromise Proposal MT
01-07 Corporate adviser firm Sodali hires Crawford for shareholder advisory, Micci for comms RE
01-07 Amrize to Buy Aggregates Business PB Materials; Shares Up Pre-Bell MT
01-07 European stocks pause rally as traders assess Venezuela fallout ahead of data RE
01-07 Swisscom Unit, TIM to Expand 5G Coverage in Italy MT
No results for this search
Detailed heatmap
  1. Stock Market
  2. Indices
  3. SMI
  4. News SMI
  5. News of the index components